Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real‐world study-Reference-Cited by-同舟云学术

Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real‐world study

Published:2021-06-22 Issue:5 Volume:8 Page:3783-3790
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Chen Wenwen¹,Liu Yanlin¹,Li Yuanmin²,Dang Heqin¹

Affiliation:

1. Department of Pharmacy the Second Affiliated Hospital of Shandong First Medical University 366 Taishan Street Tai'an 271000 China

2. Department of Cardiology the Second Affiliated Hospital of Shandong First Medical University 366 Taishan Street Tai'an 271000 China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13491

Reference28 articles.

1. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

2. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

3. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

4. Insights into implementation of sacubitril/valsartan into clinical practice

5. Ejection fraction improvement and reverse remodeling achieved with sacubitril/valsartan in heart failure with reduced ejection fraction patients;Almufleh A;Am J Cardiovasc Dis,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulse wave-based evaluation of the blood-supply capability of patients with heart failure via machine learning;BioMedical Engineering OnLine;2024-01-19

2. Use of sacubitril/valsartan in patients with heart failure: evidence from the real world;Expert Opinion on Pharmacotherapy;2023-12-05

3. Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real‐world study;ESC Heart Failure;2023-03-29

4. Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction;Frontiers in Cardiovascular Medicine;2023-03-22

5. Efficacy and safety of low‐dose sacubitril/valsartan in heart failure patients: A systematic review and meta‐analysis;Clinical Cardiology;2023-01-17